T1	Participants 349 386	6797 patients with ejection fractions
T2	Participants 477 508	Patients were randomly assigned
T3	Participants 647 674	Patients with heart failure
T4	Participants 882 890	patients
T5	Participants 1107 1124	362 placebo group
T6	Participants 1175 1201	288 in the enalapril group
T7	Participants 1250 1267	595 placebo group
T8	Participants 1317 1343	499 in the enalapril group
T9	Participants 1437 1448	711 placebo
T10	Participants 1450 1462	615 enalapri
